Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin in PCOS
NCT01118598Phase 4Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Jun 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of laropiprant in polycystic ovary syndrome (PCOS), sponsored by Hull University Teaching Hospitals. Started Jun 2010; status: completed.
02
Drugs
laropiprant
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT01118598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01118598.